$EDAP News

EDAP To Change Name To FocalTherics With Strategic Shift To High-Growth Robotic Focal Therapy; Will Trade Under Symbol FOCL From June 1

EDAP TMS Strikes Letter Of Intent with Telix Pharmaceuticals To Mull Joint Clinical Research Initiatives, Physician Education On Combination Of HIFU, PSMA PET Imaging Products For Prostate Cancer

EDAP TMS S.A. (EDAP) Q1 2026 Earnings Call Transcript

EDAP TMS (NASDAQ:EDAP) Q1 Revenue Beats as HIFU Momentum Accelerates

Edap TMS Sees FY2026 Sales $72.000M-$80.000M vs $74.601M Est.

Edap TMS Q1 EPS $(0.24) Misses $(0.22) Estimate, Sales $17.812M Beat $16.570M Estimate.

EDAP TMS Announces Publication Of HIFI-2 Study, Nationwide Trial Evaluating Salvage HIFU Using Focal One Robotic HIFU For Treatment Of Localized Prostate Cancer Recurrence Following Radiotherapy

HC Wainwright & Co. Maintains Buy on Edap TMS, Lowers Price Target to $10

EDAP TMS SA -ADR (NASDAQ:EDAP) Reports Mixed Q4 2025 Results with Strong HIFU Growth but Widening Losses

EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript

Edap TMS Q4 EPS $(0.25) Misses $(0.16) Estimate, Sales $21.880M Beat $21.320M Estimate

EDAP TMS S.A.'s (NASDAQ:EDAP) market cap surged US$14m last week, individual investors who have a lot riding on the company were rewarded

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

EDAP TMS Expects Q4 HIFU Revenue To Range Between $12.9M - $13.3M, Annual 2025 Global HIFU Revenue Between $36.7M - $37.2M

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU

EDAP TMS Gets FDA Clearance For New Ultrasound Imaging And Workflow Enhancements To Focal One High Intensity Focused Ultrasound System

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

Edap TMS SA (EDAP) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth in HIFU

EDAP TMS S.A. (EDAP) Q3 2025 Earnings Call Transcript

EDAP Reports Third Quarter 2025 Financial Results